Dindolyl Methane, or DIM as it is commonly referred to, is a very popular supplement for bodybuilders and others who are interested in increasing the growth of their muscles. Recent research has shown that DIM could pose health risks. DIM can cause liver damage when taken in excess. Another risk is kidney damage, which may result in kidney failure. The potential long-term health risks associated with DIM cause many athletes and bodybuilders ask the question: should I use an supplement with DIM?
The majority of people take a diindolylmethane supplement to improve the production of testosterone. Testosterone is known to act as an anandrogen, meaning that it can cause hormonal changes in tissues. Research has shown DIM to mimic the effects both of testosterone and other hormones. Certain manufacturers have added diindolylmethane (DIM) to their products to boost their appeal to males since men are more likely to produce testosterone than women. The theory is that men respond to a product which mimics the effects of natural testosterone.
In the end, many companies advertise DIM as a cancer suppressor. Although diindolylmethane is effective in reducing tumor growth in laboratory animals it was administered orally to the animals. In order for humans to experience the same result diindolylmethane has to be administered in large doses over a long duration. Additionally, even though the animals studied remained cancer free for several years however, they all developed liver disease at some point, probably due to the excessive diindolylmethane being present in their bodies. To have a closer glimpse of how DIM works in the body, you should seek out a medical professional.
According to the US National Institute of Environmental Health Safety and Security, the only way to demonstrate that DIM is effective in treating breast cancer is to perform an experiment where cells from healthy breast cancer cells are exposed to high doses of diindolylmethane for a long period of time. As with any chemical, there are both pros and cons associated with using it. The advantages include the capability to mimic hormones. This allows you to make insulin which can inhibit cancer cell growth. The disadvantages are that diindolylmethane also produces potentially damaging chemical called DMSO. Learn more about what is diindolylmethane here.
One of the most common claims made about diindolylmethane’s use in a treatment for various diseases is that it acts as an anti-cancer, natural, antibacterial and anti-fungal agent. The National Institute of Health, through an exhaustive study of supporting data found no evidence to support these claims. According to the Institute of Chemical Technology there was no evidence from any research that support this claim. In a comprehensive study of the safety profile of the firestone the Institute of Chemical Safety concluded that the evidence from pharmaceutical companies on the benefits for humans of diindolylmethane was not reliable.
In a May 2021 edition of the Journal of Toxicology and Environmental Health, van der Goes, and others. Van der Goes, and. have highlighted the potential dangers of diindolylmethane, which includes allergic reactions to the skin asthma attacks, as along with headaches, dizziness and respiratory issues. The daily dosage recommended for this chemical, which is approximately one tenth to a teaspoon, was 0.2 milligrams. It isn’t clear what the concentration is when it is compounded with other compounds. This substance is not considered safe because it has not been thoroughly test.
The abstract of the view shows the use of diindolylmethane in cancer treatment is based on the principle that intracellular inhibition of pyruvate metabolism through flavenoids is a possibility to block and prevents the accumulation of Oxalates and pyruvate-derived metabolites in renal tubule cells. The toxicology studies of the drug metabiplicate have not shown that this chemical could cause overdose. The Food and Drug Administration approved this substance as a prescription drug in June 1996. According to the FDA the manufacturer of firestone tincture is in the process of conducting two major studies – one in Europe and another in the United States.
The abstract of the view also indicates that diindolylmethane’s usage in the treatment of cancer is based on the concept of inhibiting intracellular inhibition by flavenoids of pyruvate metabolism and thus hindering the accumulation of oxalates and adenine in the renal tubule cells. The drug metabiplicate toxicology studies have not proven that this chemical can cause overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA the manufacturer of firestone tincture is in process of completing two major studies – one in Europe and another in the United States. According to FDA, the FDA states that the maker of the tincture is currently completing two major trials in Europe and one in the United States.